Loading
Intensive Care Unit Cognitive Disorders / Cancer, Stress, Anesthesia, and Immune Response · Journal article
Biomedicine & Pharmacotherapy · July 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This ex vivo mechanistic study reports that Alzheimer's-like transgenic mouse brain tissue (APPPS1) exhibits impaired metabolic reserve during neuronal stimulation despite preserved baseline oxygen consumption, and that isoflurane suppresses metabolism in a concentration-dependent manner in both genotypes. The findings suggest a cellular basis for increased perioperative vulnerability in AD but do not establish clinical causation or translate directly to human disease or anesthetic outcomes.
Ex vivo mechanistic study in transgenic mouse brain slices. Wild-type (WT) and APPPS1 transgenic mice; acute brain slices from entorhinal cortex. Intervention: Isoflurane exposure at 1% and 3% concentration. Compared with: Control (unstimulated) conditions and WT tissue.
APPPS1 brain slices showed reduced stimulation-induced increases in CMRO₂ compared with WT tissue, indicating diminished metabolic reserve Unstimulated oxygen consumption differed modestly between genotypes Isoflurane suppressed CMRO₂ in a concentration-dependent manner in both genotypes
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Results suggest a potential mechanism for increased anesthetic-related complications in Alzheimer's disease patients, but the ex vivo slice model and lack of behavioral or clinical outcome data limit direct applicability to perioperative risk assessment or management.
Mechanistic ex vivo study in transgenic mouse brain tissue showing reduced metabolic reserve in Alzheimer's-like pathology during anesthesia; lacks clinical translation and in vivo validation.
As stated by the source record.
Quoted from the source exactly as published.
Results suggest a potential mechanism for increased anesthetic-related complications in Alzheimer's disease patients, but the ex vivo slice model and lack of behavioral or clinical outcome data limit direct applicability to perioperative risk assessment or management.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
General anesthesia is an essential component of modern surgical and diagnostic care. Although it is overall safe in younger and healthy individuals, the situation is markedly different in patients with underlying neurological conditions like Alzheimer´s disease (AD), where perioperative neurological complications are common. However, the underlying mechanisms and tissue-level interaction between AD-related pathology, cerebral energy metabolism, and anesthetic exposure remain incompletely understood. We investigated acute entorhinal cortex slices from wild-type (WT) and AD-like APPPS1 transgenic mice under control conditions and sequentially exposed them to 1% and 3% isoflurane. Depth-resolved oxygen measurements were used to calculate the cerebral metabolic rate of oxygen (CMRO₂), while extracellular potassium dynamics were recorded using ion-sensitive microelectrodes. Glial markers were assessed by immunohistochemistry, and proteomic profiling was integrated with kinetic metabolic modeling. APPPS1 brain slices showed reduced stimulation-induced increases in CMRO₂ compared with WT tissue, indicating diminished metabolic reserve, whereas unstimulated oxygen consumption differed modestly between genotypes. Isoflurane suppressed CMRO₂ in a concentration-dependent manner in both genotypes. Extracellular potassium levels increased with isoflurane, whereas stimulation-induced potassium transients were reduced, with largely preserved clearance dynamics across genotypes. Immunohistochemistry confirmed microglial activation in APPPS1 tissue but revealed no acute isoflurane-induced glial response. Proteomics consequently indicated immune and inflammatory remodeling, whereas metabolic modeling suggested reduced glycolytic capacity under high energetic demand. Thus, APPPS1 entorhinal cortex tissue retains unstimulated metabolic function but exhibits impaired metabolic reserve during neuronal activation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.